Concepedia
Statistics
Publications
4
Citations
76
H-Index
Active since
2011
Affiliations
Eli Lilly (United States)(Current)
Michael Amatulli is an author at Eli Lilly (United States).
Publications per year
2011–2024
Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor
Amélie Forest, Michael Amatulli, Dale L. Ludwig et al. · Molecular Cancer Research · 2015 · 28 citations · Full text
Pleiotropic Stromal Effects of Vascular Endothelial Growth Factor Receptor 2 Antibody Therapy in Renal Cell Carcinoma Models
Inga Duignan, Erik Corcoran, Anthony L. Pennello et al. · Neoplasia · 2011 · 19 citations · Full text
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
Jiaxi Wu, Nicolin Bloch, Aaron Y. Chang et al. · Cell Reports Medicine · 2024 · 17 citations · Full text
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth
Maria B. Lebron, Laura Brennan, Christopher B. Damoci et al. · Cancer Biology & Therapy · 2014 · 12 citations · Full text
1–4 of 4